Is BEAM a good stock to buy? We came across a bullish thesis on Beam Therapeutics Inc. on r/ValueInvesting by Significant-Pair-275. In this article, we will summarize the bulls’ thesis on BEAM. Beam Therapeutics Inc.'s share was trading at $30.69 as of April 21st.
Beam Therapeutics (BEAM) is a clinical-stage gene-editing company developing next-generation base editing therapies designed to make precise, permanent genetic corrections without the double-strand DNA breaks associated with traditional CRISPR approaches. The investment case is increasingly driven by emerging...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.